1921
Volume 103, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Approximately 20% of patients infected with SARS-CoV-2 (COVID-19) develop potentially life-threatening pathologies involving hyperinflammation, cytokine storm, septic shock complications, coagulation dysfunction, and multiple organ failure. Blood levels of the prototypic acute phase reactant, C-reactive protein (CRP), which is hepatically synthesized and released in response to interleukin-6 stimulation, is markedly elevated in patients with COVID-19. Markedly high CRP levels correlate with poor prognosis for survival. Insights into CRP structure–function relationships have uncovered both pro- and anti-inflammatory isoforms that may be used to monitor the extent of tissue damage associated with COVID-19 pathologies and prognoses. Herein, rationale is given for interpretation of CRP blood levels as a simple, rapid, and cost-effective way to assess disease severity and help guide therapeutic options in COVID-19 patients.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.20-0473
2020-06-25
2020-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/103/2/tpmd200473.html?itemId=/content/journals/10.4269/ajtmh.20-0473&mimeType=html&fmt=ahah

References

  1. Guo Y, Cao Q, Hong Z, Tan Y-Y, Chen S-D, Jin H-J, Tan K-S, Wang D-Y, Yan Y, 2020. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res 7: 11.
    [Google Scholar]
  2. Singha TA, 2020. Review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 87: 281286.
    [Google Scholar]
  3. Zhou S, Wang Y, Zhu T, Xia LCT, 2020. Features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. Am J Roentgenol 214: 12871294.
    [Google Scholar]
  4. Moore JB, June CH, 2020. Cytokine release syndrome in severe COVID-19. Science 368: 473474.
    [Google Scholar]
  5. Eklund CM, 2009. Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48: 111136.
    [Google Scholar]
  6. Vigushin DM, Pepys MB, Hawkins PN, 1993. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91: 13511357.
    [Google Scholar]
  7. Antonelli M, Kushner I, 2017. It’s time to redefine inflammation. FASEB J 31: 17871791.
    [Google Scholar]
  8. WHO, 2014. C-Reactive Protein Concentrations as a Marker of Inflammation or Infection for Interpreting Biomarkers of Micronutrient status. Geneva, Switzerland: World Health Organization. Vitamin and Mineral Nutrition Information System. (WHO/NMH/NHD/EPG/14.7). Available at: http://apps.who.int/iris/bitstream/10665/133708/1/WHO_NMH_NHD_EPG_14.7_eng.pdf?ua=1. Accessed March 19, 2020.
    [Google Scholar]
  9. Federal Drug Administration (FDA), U.S. Department of Health and Human Services, 2015. Guidance for Industry and FDA Staff. Review Criteria for Assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive Protein (hsCRP) and Cardiac C-Reactive Protein (cCRP) Assays. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/review-criteria-assessment-c-reactive-protein-crp-high-sensitivity-c-reactive-protein-hscrp-and-0. Accessed March 19, 2020.
    [Google Scholar]
  10. Butler CC et al., 2019. C-reactive protein antibiotics prescribing for COPD exacerbations. N Engl J Med 381: 111120.
    [Google Scholar]
  11. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD, 2020. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy doi:10.1111/all.14238. Epub ahead of print, Feb 19.
    [Google Scholar]
  12. Wu W, Shi D, Fang D, Guo F, Guo J, Huang F, Chen Y, Lv L, Li L, 2016. A new perspective on C-reactive protein in H7N9 infections. Int J Infect Dis 44: 3136.
    [Google Scholar]
  13. Zhang J, Zhou L, Yang Y, Peng W, Wang W, Chen X, 2020. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Resp Med 8: E11E12.
    [Google Scholar]
  14. Cawcutt K, Kalil AC, 2017. Pneumonia with bacterial and viral coinfection. Curr Opin Crit Care 23: 385390.
    [Google Scholar]
  15. Hanada S, Pirzadeh M, Carver KY, Deng JC, 2018. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol 6: 2640.
    [Google Scholar]
  16. MacIntyre CR, Chughtai AA, Barnes M, Ridda I, Seale H, Toms R, Heywood A, 2018. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09. BMC Infect Dis 18: 637.
    [Google Scholar]
  17. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, Jian X, Li X, 2020. C-reactive protein correlates with CT findings and predicts severe COVID-19 early. J Med Virol 92: 856862.
    [Google Scholar]
  18. Wang L, 2020. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect 50: 332334.
    [Google Scholar]
  19. Guan W et al., 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382: 17081720.
    [Google Scholar]
  20. Richardson S et al., The Northwell COVID-19 Research Consortium, 2020. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323: 20522059.
    [Google Scholar]
  21. Liu F, Li L, Xu M, Wu J, Luo D, Zhu YS, Li BX, Song XY, Zhou X, 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 127: 104370.
    [Google Scholar]
  22. Wu Y, Potempa LA, Kebir DE, Filep JG, 2015. C-reactive protein and inflammation: conformational changes affect function. Biol Chem 396: 11811197.
    [Google Scholar]
  23. McFadyen JD, Kiefer J, Loseff-Silver J, Potempa LA, Eisenhardt SU, Peter K, 2018. Dissociation of C-reactive protein localizes and amplifies inflammation: evidence for a direct biological role of CRP and its conformational changes. Front Immunol 9: 1351.
    [Google Scholar]
  24. Molins B, Peña E, de la Torre R, Badimon L, 2011. Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C reactive protein on adhered activated platelets under flow. Cardiovasc Res 92: 328337.
    [Google Scholar]
  25. Xu X et al., 2020. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA 117: 1097010975.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.20-0473
Loading
/content/journals/10.4269/ajtmh.20-0473
Loading

Data & Media loading...

  • Received : 12 May 2020
  • Accepted : 19 Jun 2020
  • Published online : 25 Jun 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error